MK-0159 (compound 37) 是一种口服有效的和选择性的CD38抑制剂，对人、小鼠和大鼠 CD38 的IC50分别为 22、3 和 70 nM。MK-0159 对人和啮齿动物的肝脏微粒体也显示出良好的稳定性。MK-0159 增加全血和心脏的 NAD+(烟酰胺腺嘌呤二核苷酸)，降低ADPR(二磷酸腺苷核糖)。

MK-0159 (compound 37) is an orally active, potent and selective CD38 inhibitor, with IC 50 values of 22, 3, and 70 nM for human, mouse and rat CD38, respectively. MK-0159 also shows good microsomal stability for human and rodent liver microsomes. MK-0159 increases NAD + (nicotinamide adenine dinucleotide) and reduces ADPR (adenosine diphosphate ribose) in whole blood and heart [1].

2641484-61-7

C20H24N4O3S

400.49

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years